AxCellerate supports translational research in neuroscience with human-relevant Brain-on-Chip models for preclinical evidence generation.
Translational research plays a critical role in neuroscience drug development. Its goal is to connect experimental findings with biological mechanisms that are more relevant to human disease, helping research teams move from scientific hypothesis to stronger preclinical evidence.
In neuroscience, this transition is particularly challenging. Conventional models often have limited ability to reproduce the complexity of human neuronal systems, making it difficult to predict how a compound, target or disease mechanism may behave in a human context.
AxCellerate supports translational research through Brain-on-Chip technology and three-dimensional human-derived neuronal models. The platform is designed to help research teams investigate neuronal activity, disease-related mechanisms, compound response and target biology in a more human-relevant experimental environment.
AxCellerate’s Brain-on-Chip platform provides advanced capabilities for research programs that need stronger translational relevance.
The technology can help by providing:
Three-dimensional human-derived neuronal systems help bridge the gap between conventional preclinical models and human biology.
Electrophysiological recording capabilities provide insights into neuronal activity and network response, adding functional value to preclinical evidence.
The platform can support the study of neurological and neurodegenerative mechanisms in models designed around specific scientific questions.
Candidate compounds and therapeutic targets can be assessed in a more relevant neuronal context to support early-stage decision-making.
AxCellerate’s models can complement existing research strategies, providing additional evidence for internal R&D, collaborative research or translational programs.
Each study can be structured around the research objective, disease area, biological question and required outputs.
Advantages
AxCellerate provides a specialized approach for organizations that need to strengthen the connection between preclinical data and human-relevant biology.
By applying Brain-on-Chip technology to translational neuroscience, AxCellerate helps research teams generate more relevant evidence, reduce uncertainty and support better-informed decisions across preclinical development.
